2017 EACPT Scientific Award goes to David Webb, United Kingdom

Publication: Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2). Journal: Lancet 105; 386(10008): 2059–68.